* Penumbra Inc PEN.N reported quarterly adjusted earnings
of 76
cents per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of 16
cents. The mean expectation of fourteen analysts for the
quarter was for earnings of 70 cents per share. Wall Street
expected results to range from 57 cents to 87 cents per share.
* Revenue rose 28.7% to $284.68 million from a year ago;
analysts
expected $286.56 million.
* Penumbra Inc's reported EPS for the quarter was $1.38.
* The company reported quarterly net income of $54.22
million.
* Penumbra Inc shares had risen by 2.7% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Penumbra Inc is
$286.50
This summary was machine generated from LSEG data February 23 at
03:07 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 0.70 0.76 Beat
Sep. 30 2023 0.45 0.67 Beat
Jun. 30 2023 0.28 0.43 Beat
Mar. 31 2023 0.11 0.23 Beat